Why does AMGN insist enbrel is safe for dermatology?
I guess I don't understand why they would push the safety of their product given reports from credible sources that at least those patients with a predisposition to MS can be negatively impacted. I understand doctors can initiate prescription of enbrel for psoriasis and there seems to be a bit of loophole in the situation. But there is a risk here that the effects of enbrel will start showing up after years of use and the incidence of MS like symptoms in such patients will climb appreciably.
Hopefully doctors will stop prescribing enbrel except for crippling conditions. I am looking into whether there is a hint of this in the declining growth of enbrel in dermatology.
I think the company and the market should be more cautious here.
One has to be careful in what one says. I do believe it is important to write responsibly even in these informal forums. I would post links but yahoo rejects them. So I posted the relevant info in seeking alpha. My opinion can not be said to be based on hard science. It is NOT hard science. The science simply is not there as far as I can tell.
However I do believe that there is reason for concern. This is based on public information available to anyone but difficult to interpret because the incidence of MS is uncertain. Nevertheless that does not mean everything is fine.